![Ronit Simantov](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 31/05/2026
Ronit Simantov currently works at TempestTx, Inc., as Director and Gamida Cell Ltd., as Chief Medical & Scientific Officer.
Dr. Simantov also formerly worked at Bayer HealthCare Pharmaceuticals, Inc., as Oncology Director in 2007, Clovis Oncology, Inc., as Independent Director from 2021 to 2023, Tempest Therapeutics, Inc., as Independent Director from 2021 to 2026, Pfizer Inc., as Head-Oncology Global Medical Affairs from 2011 to 2017, CuraGen Corp., as Chief Medical Officer from 2007 to 2009, and OSI Pharmaceuticals, Inc., as Vice President-Clinical Research from 2010 to 2011.
Dr. Simantov received her undergraduate degree from The Johns Hopkins University and doctorate degree from New York University School of Medicine.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 27/01/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GAMIDA CELL LTD. | Director Técnico/Científico/I+D | 01/07/2017 |
TempestTx, Inc.
 TempestTx, Inc. BiotechnologyHealth Technology Develops novel therapies for oncology | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
| TEMPEST THERAPEUTICS, INC. | Director/Miembro de la Junta | 23/05/2026 |
| CLOVIS ONCOLOGY, INC. | Director/Miembro de la Junta | 10/07/2023 |
| PFIZER INC. | Corporate Officer/Principal | 01/06/2017 |
| OSI PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/06/2011 |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Director Técnico/Científico/I+D | 01/09/2009 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical drugs | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology Develops protein, antibody and small molecule pharmaceutical products | Health Technology |
TempestTx, Inc.
TempestTx, Inc. BiotechnologyHealth Technology Develops novel therapies for oncology | Health Technology |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Health Technology |
Gamida Cell Ltd.
 Gamida Cell Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases | Health Technology |
Clovis Oncology, Inc.
 Clovis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as an biopharmaceutical company that acquires, develops and commercializes innovative anti cancer agents | Health Technology |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tempest Therapeutics, Inc.
 Tempest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology pharmaceuticals | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
